Chapter 22. Genomics and its Role in Cancer Risk Assessment

  1. Ching-Hung Hsu and
  2. Todd Stedeford
  1. Banalata Sen1,
  2. Douglas C. Wolf2 and
  3. Vicki Dellarco3

Published Online: 5 AUG 2010

DOI: 10.1002/9780470622728.ch22

Cancer Risk Assessment

Cancer Risk Assessment

How to Cite

Sen, B., Wolf, D. C. and Dellarco, V. (2010) Genomics and its Role in Cancer Risk Assessment, in Cancer Risk Assessment (eds C.-H. Hsu and T. Stedeford), John Wiley & Sons, Inc., Hoboken, NJ, USA. doi: 10.1002/9780470622728.ch22

Editor Information

  1. Health, Safety & Environment, Albemarle Corporation, Baton Rouge, Louisiana, USA

Author Information

  1. 1

    Science Education and Outreach Program Manager, Environmental Health Perspectives, DHHS, NIH, NIEHS, Durham, North Carolina, USA

  2. 2

    National Health and Environmental Effects Research Laboratory (NHEERL), Office of Research and Development (ORD), United States Environmental Protection Agency, Research Triangle Park, North Carolina, USA

  3. 3

    Office of Pesticide Programs, United States Environmental Protection Agency, Washington, D.C., USA

Publication History

  1. Published Online: 5 AUG 2010
  2. Published Print: 6 JUL 2010

ISBN Information

Print ISBN: 9780470238226

Online ISBN: 9780470622728



  • genomics and its role in cancer risk assessment;
  • proteomics, a semiquantitative evaluation of proteins - translated from expressed genes to specific analysis and quantitation of individual proteins;
  • genomics and new risk assessment paradigm


This chapter contains sections titled:

  • Introduction

  • “-Omics” Technologies

  • Genomics and the New Risk Assessment Paradigm

  • Case Studies

  • Use of Genomics in Predictive Toxicology

  • Conclusions

  • References